bioRxiv/medRxiv TRiP Review Activity

78 Reviews — EMBO Press — Cancer Biology

Most recent first Previous |  Page 2: Articles 11-20  | Next

TUMOR ENDOTHELIAL CELL AUTOPHAGY IS A KEY VASCULAR-IMMUNE CHECKPOINT IN MELANOMA
Verhoeven, J., Jacobs, K. A., Rizzollo, F., Lodi, F., Hua, Y., Pozniak, J., Srinvasan, A. N., Houbaert, D., Shankar, G., More, S., Schaaf, M. B., Dubroja Lakic, N., Ganne, M., Lamote, J., Van Weyenbergh, J., Boon, L., Bechter, O., Bosisio, F., Bertrand, M., Marine, J. C., Lambrechts, D., Bergers, G., Agrawal, M., Agostinis, P.
10.1101/2023.04.21.537799 — Posted: 2023-04-21 — Discussion: 2023-12-16  EMBO Press
Paralog dispensability shapes homozygous deletion patterns in tumor genomes
De Kegel, B., Ryan, C. J.
10.1101/2022.06.20.496722 — Posted: 2022-06-20 — Discussion: 2023-12-13  EMBO Press
Downregulation of stromal syntenin sustains AML development
Leblanc, R., Ghossoub, R., Goubard, A., Castellano, R., Fares, J., Camoin, L., Audebert, S., Balzano, M., Boutayeh, B., Fauriat, C., Vey, N., Borg, J.-P., Collette, Y., Aurrand-Lions, M., David, G., Zimmermann, P.
10.1101/2023.02.15.527799 — Posted: 2023-02-15 — Discussion: 2023-12-12  EMBO Press
NRF2 connects Src tyrosine kinase to ferroptosis resistance in glioblastoma
Barila, D., Cirotti, C., Taddei, I., Contadini, C., Pepe, G., De Bardi, M., Borsellino, G., Helmer-Citterich, M.
10.1101/2023.05.08.539792 — Posted: 2023-05-09 — Discussion: 2023-12-09  EMBO Press
YAP antagonizes TEAD-mediated AR signaling and prostate cancer growth
Zhuo, S., Li, X., Cho, Y. S., Liu, Y., Yang, Y., Zhu, J., Jiang, J.
10.1101/2022.08.01.502314 — Posted: 2022-08-03 — Discussion: 2023-12-01  EMBO Press
PTEN deficiency exposes a requirement for an ARF GTPase module in integrin-dependent invasion in ovarian cancer.
Nikolatou, K., Sandilands, E., Roman-Fernandez, A., Cumming, E. M., Freckmann, E. C., Lilla, S., Buetow, L., McGarry, L., Neilson, M., Shaw, R., Strachan, D., Miller, C., Huang, D. T., McNeish, I. A., Norman, J. C., Zanivan, S., Bryant, D.
10.1101/2022.11.29.518198 — Posted: 2022-11-29 — Discussion: 2023-09-06  EMBO Press
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
Iyer, S. R., Nusser, K., Jones, K., Shinde, P., Beach, C. Z., Keddy, C., Aguero, E., Force, J., Shinde, U., Davare, M. A.
10.1101/2022.12.27.521482 — Posted: 2022-12-27 — Discussion: 2023-09-02  EMBO Press
NLRP3 controls ATM activation in response to DNA damage.
PETRILLI, V., Bodnar-Wachtel, M., Huber, A.-L., Gorry, J., Hacot, S., Gerossier, L., Guey, B., Goutagny, N., Bartosch, B., Ballot, E., Ghiringhelli, F., Py, B., Coute, Y., Ballesta, A., Lantuejoul, S., Hall, J.
10.1101/2020.05.12.087015 — Posted: 2020-05-14 — Discussion: 2023-08-26  EMBO Press
ATR inhibition augments the efficacy of lurbinectedin in small cell lung cancer
Schultz, C. W., Zhang, Y., Elmeskini, R., Zimmermann, A., Fu, H., Murai, Y., Wangsa, D., Kumar, S., Takahashi, N., Atkinson, D., Saha, L. K., Lee, C.-F., Elenbaas, B., Desai, P., Sebastian, R., Ried, T., Aladjem, M., Zenke, F. T., Weaver, Z., Pommier, Y., Thomas, A.
10.1101/2022.12.16.520783 — Posted: 2022-12-19 — Discussion: 2023-08-02  EMBO Press
Highly multiplexed quantitative phosphosite assay for biology and preclinical studies
Keshishian, H., McDonald, E. R., Melanson, R., Porter, D. A., Mundth, F., Krug, K., Wallace, L., Forestier, D., Rabasha, B., Marlow, S. E., Jane-Valbuena, J., Todres, E., Specht, H., Golji, J., Kuhn, E., Burgess, M., MacMullan, M., Satpathy, S., Mani, D. R., Gillette, M., Clauser, K., Rejtar, T., Wang, K., Garraway, L. A., Sellers, W. R., Carr, S. A.
10.1101/2020.12.08.415281 — Posted: 2020-12-09 — Discussion: 2023-06-10  EMBO Press

Evaluation Sources